Autoplaque vs AI-ECG Platform
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for clinicians seeking precise measurements of plaque burden, characterization of plaque types, and accurate stenosis assessment to inform heart attack risk prediction and guide treatment strategies for structural coronary artery disease.
View Autoplaque →Choose AI-ECG Platform if…
Choose the AI-ECG Platform if you require rapid and highly accurate AI-assisted interpretation of 12-lead resting ECGs. This system is best suited for physicians needing quick diagnostic support for a broad spectrum of cardiac conditions, including arrhythmias, myocardial ischemia, and infarction, particularly in busy clinical environments where immediate analysis of cardiac electrical activity is critical.
View AI-ECG Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | AI-ECG Platform |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | On-premise (AI-ECG Workstation), web-based (Management Portal), and client-based (AI-ECG Diagnostic Client). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-ECG PlatformTool B offers more flexible deployment options, including a web-based portal and a Windows-based diagnostic client, which generally enhances accessibility and ease of use for various clinical settings. Its emphasis on rapid diagnosis in approximately 3 seconds also suggests a highly efficient workflow. Tool A, while workstation-based and clinician-reviewable, does not explicitly offer the same level of deployment flexibility or speed.
Clinical Value
AutoplaqueAutoplaque provides a more specialized and potentially higher-impact clinical insight by offering quantitative analysis of coronary plaques and luminal stenoses from CT angiography images for heart attack risk prediction and treatment guidance. While the AI-ECG Platform offers high accuracy for common ECG diagnoses, Autoplaque's focus on advanced, quantitative risk stratification from CTA images represents a distinct and significant clinical advancement.
Pricing & Value
TieBoth tools have undisclosed pricing information, making it impossible to conduct a head-to-head comparison of their value proposition. Without any cost details, a meaningful assessment of which tool offers better value cannot be made.
Enterprise Readiness
AI-ECG PlatformTool B clearly demonstrates greater enterprise readiness with its web-based management portal for organization settings, security, and task management. It also supports multiple standard ECG data formats (Carewell ECG, HL7 aECG, DICOM ECG, SCP ECG, MFER ECG), which are crucial for integration into existing healthcare IT infrastructures. Tool A is purely workstation-based and lacks explicit statements on enterprise-level features or data format compatibility.
Innovation
AutoplaqueAutoplaque demonstrates greater innovation by providing AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, specifically for heart attack risk prediction. This represents a more advanced and novel application of AI in cardiology compared to the AI-driven interpretation of standard 12-lead ECGs, which is a more established area, even with high accuracy and speed.
Support & Docs
TieNeither the provided structured facts nor web searches offer any information regarding the availability or quality of support and documentation for either Autoplaque or the AI-ECG Platform. Therefore, it is impossible to distinguish between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | AI-ECG Platform |
|---|---|---|
| Name | Autoplaque | AI-ECG Platform |
| Company | Cedars-Sinai Medical Center: AIM | Shenzhen Carewell Electronics Co., Ltd. |
| Description | FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | FDA-cleared artificial intelligence (AI) automatic analysis and diagnosis system for ECG, designed to assist physicians in interpreting 12-lead resting ECGs with high accuracy. |
| Primary Clinical Focus | Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images | Automatic analysis and diagnosis system for 12-lead resting ECGs |
| Key Features (Selection) | AI-powered quantitative analysis of atherosclerotic plaque; Detection and characterization of coronary artery plaque; Measurement of luminal stenoses | AI-powered automatic ECG analysis and diagnosis; Over 95% accuracy in diagnosing major cardiovascular diseases; Diagnoses arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and AI-ECG Platform.